![]() |
市场调查报告书
商品编码
1370643
注射避孕药市场- 按类型(仅黄体酮注射剂{长效醋酸甲羟孕酮})、年龄组(15-24 岁、25-34 岁)、作用持续时间(短效注射避孕药)、最终用户、全球预测、 2023-2032Injectable Contraceptives Market - By Type (Progesterone-only Injectables {Depot Medroxyprogesterone Acetate}), Age Group (15-24 Years, 25-34 Years), Duration of Action (Short-acting Injectable Contraceptives), End-user, Global Forecast, 2023-2032 |
2023 年至 2032 年间,全球注射避孕药市场的复合年增长率将达到 3.5%。由于注射避孕药领域的创新和研究发现不断增加,该产业将持续扩张。例如,2023年10月,印度医学研究委员会(ICMR)在避孕领域取得了突破性进展,成功完成了世界首创的男性注射避孕药的临床试验。这些试验证明了该方法的安全性和显着的有效性,没有任何明显的副作用。第三阶段试验涉及 303 名年龄在 25 岁至 40 岁之间的候选人。 ICMR的临床试验结果最近发表在国际公认的男科学杂誌上。
配方、给药方法和功效的不断进步正在扩大女性和男性的避孕选择。这些创新不仅扩大了选择,还提高了避孕注射剂的便利性和可靠性,从而推动了避孕注射剂市场的成长。
整个注射避孕药市场根据类型、最终用户和地区进行分类。
复方注射避孕药细分市场将在 2023 年至 2032 年间经历重大发展。这些配方包含多种激素,可为女性提供高效的节育选择。 CIC 的便利性和有效性以及副作用的减少使其越来越受欢迎。随着女性寻求可靠的避孕选择,注射避孕药市场前景对复方注射避孕药的需求持续成长。
妇科诊所领域从 2023 年到 2032 年将实现显着的复合年增长率。这些医疗机构越来越多地提供注射避孕药,作为女性方便有效的节育选择。妇科诊所提供的专业知识和服务使其成为寻求专家指导和护理的人的自然选择。这一趋势反映出人们更广泛地转向可及且可靠的避孕解决方案,从而促进了注射避孕药市场的扩张。
欧洲注射避孕药市场从 2023 年到 2032 年将呈现可观的复合年增长率。这归因于该地区不断进步的医疗基础设施以及女性对避孕选择的认识不断提高。欧洲女性正在转向注射避孕药作为安全、方便的选择。由于注重生殖健康和知情选择,欧洲对注射避孕药具的需求将会成长,使其成为全球市场的重要部分。
Global Injectable Contraceptives Market will witness 3.5% CAGR between 2023 and 2032. The industry is set on expansion due to the growing number of innovations and research discoveries in the realm of injectable contraceptives. For instance, in October 2023, a groundbreaking development in the contraceptive field came from the Indian Council of Medical Research (ICMR), which successfully concluded clinical trials for the world's pioneering injectable male contraceptive. These trials demonstrated both safety and remarkable effectiveness of the method, devoid of any significant adverse effects. The phase-3 trials involved 303 candidates aged between 25 and 40 years. The results of ICMR's clinical trials were recently published in the internationally accessible Andrology journal.
Ongoing advancements in formulation, delivery methods, and efficacy are expanding contraceptive options for women and men. These innovations are not only broadening choice but also improving the convenience and reliability of injectable contraceptives, thus fueling the injectable contraceptive market growth.
The overall Injectable Contraceptives Market is classified based on type, end-user, and region.
Combined injectable contraceptives segment will undergo significant development from 2023 to 2032. These formulations include a combination of hormones that offer highly effective birth control options for women. The convenience and efficacy of CICs, in line with reduced side effects, have contributed to their increasing popularity. As women seek reliable contraceptive choices, the demand for combined injectable contraceptives continues to grow in the injectable contraceptives market outlook.
Gynaecology clinics segment will register a notable CAGR from 2023 to 2032. These healthcare facilities are increasingly offering injectable contraceptives as a convenient and effective birth control option for women. The specialized knowledge and services provided in gynaecology clinics make them a natural choice for those seeking expert guidance and care. This trend reflects the broader shift toward accessible and reliable contraceptive solutions, contributing to the injectable contraceptives market expansion.
Europe injectable contraceptives market will showcase an appreciable CAGR from 2023 to 2032. This is attributed to the region's progressive healthcare infrastructure and the increasing awareness among women regarding contraceptive options. European women are turning to injectable contraceptives as a safe and convenient choice. With a focus on reproductive health and informed choices, Europe's demand for injectable contraceptives will grow, making it a prominent segment within the global market.
DATA TABLES